-
SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval
24 Oct 2025 23:38 GMT
… year and older. The new FDA approval expands the indication for the … .
How Did Stocktwits Users React?
Shares of the company soared 4% …
-
US FDA approves GSK's blood cancer treatment
24 Oct 2025 20:11 GMT
… it was withdrawn.
The FDA approved Blenrep in combination with … not included in the approval.
US-listed shares of the company … a confirmatory trial. The FDA's latest decision … those affecting vision.
The FDA approval is expected to boost investor …
-
Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
24 Oct 2025 17:58 GMT
… NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage … . Revuforj previously received FDA approval in 2024 for the … Lymphoma Society). “The FDA approval of a precision treatment that … webcast to discuss the FDA approval of Revuforj today, …
-
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
24 Oct 2025 14:58 GMT
… Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep … of therapy.
The Blenrep approval is supported by data … the requirements of the FDA Accelerated Approval regulations.
In patients … Johnson & Johnson’s (NYSE:JNJ) Darzalex (daratumumab)-based …
-
GSK’s new multiple myeloma blood cancer drug gets US approval
24 Oct 2025 13:50 GMT
… advisory committee to the FDA concluded that the overall …
Shares in GSK will be in focus when the London Stock Exchange … opens on Friday. The FDA approval was announced … a standalone company on the FTSE 100 three years ago …
-
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript
24 Oct 2025 12:26 GMT
… and 72.6 million diluted shares outstanding. In addition, we … West Pharmaceutical Services Inc (NYSE:WST) Follow West Pharmaceutical … a number of approvals by the FDA might be a little … West Pharmaceutical Services Inc (NYSE:WST) Follow West Pharmaceutical …
-
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
24 Oct 2025 12:00 GMT
… (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology … milestone, the first FDA clearance or approval for a treatment … adults. “This latest FDA clearance represents a pivotal … technology. This important approval positions NeurAxis as the …
-
Natwest raises FY income and returns guidance, GSK's Blenrep receives FDA approval
24 Oct 2025 10:57 GMT
STOCKS TO WATCH
NatWest has raised its income and returns guidance for 2025 following a strong performance in the third quarter, helped by “healthy levels of customer activity”. The lender said it now expects income excluding notable items to be around £16 …
-
Caplin Steriles Ltd receives USFDA approval for ANDA Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection
23 Oct 2025 17:04 GMT
… final approval from the United States Food and Drug Administration (USFDA) … other markets in 2026.
Shares of Caplin Point Laboratories Limited … The total number of shares traded during the day …
INE475E01026
Pharmaceuticals
CaplinSteriles
USFDA
ANDA
Approval
-
From Defence stocks, Premier Energies to Cipla – Here are 8 stocks to watch today
24 Oct 2025 01:50 GMT
… Rs 79,000 crore procurement approvals to Cipla’s new diabetes … settling at 25,891.40.
Stocks to watch on October 24 … , 2025
Defence stocks in focus
The Defence Acquisition … received final approval from the US Food and Drug Administration (USFDA) for …
About
© 1995-2025